# Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

Study · id `cardio:ct-nct06365502` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06365502](<https://clinicaltrials.gov/study/NCT06365502>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06365502

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1860 participants.

## Technical summary

Registry record NCT06365502. Randomized; single masking; primary purpose treatment. Start 2024-04-16 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1860 participants (planned count; ClinicalTrials.gov record NCT06365502, source copy `cardio:ctgov-nct06365502-2024-05-22`, retrieved 2026-10-31)
- Started: 2024-04-16 (actual) (ClinicalTrials.gov record NCT06365502, source copy `cardio:ctgov-nct06365502-2024-05-22`, retrieved 2026-10-31)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT06365502, source copy `cardio:ctgov-nct06365502-2024-05-22`, retrieved 2026-10-31)
- Completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT06365502, source copy `cardio:ctgov-nct06365502-2024-05-22`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06365502, source copy `cardio:ctgov-nct06365502-2024-05-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06365502-2024-05-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
- Condition: Acute Coronary Syndrome (ACS)
- Intervention (Device): Drug-coated balloon
- Intervention (Drug): Guideline-directed medical treatment
- Lead sponsor: Harbin Medical University
- Lead sponsor class: OTHER
- Collaborator: Shanghai Shenqi Medical Technology Co., Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Harbin Medical University (`cardio:org-harbin-medical-university`)
- Registry lists this organization as a collaborator: Shanghai Shenqi Medical Technology Co., Ltd (`cardio:org-shanghai-shenqi-medical-technology-co-ltd`)

## Provenance

Content hash: c467abd9b3fff37f197a1d0e68ff75664db51526acb169f46b92249f7a1e0108
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
